Navigation Links
Stomach Cancer Tumors Have Genetic Differences: Researchers

WEDNESDAY, Aug. 3 (HealthDay News) -- Stomach cancer tumors have genetic differences, which determine how they respond to treatment, researchers have found.

In identifying two distinct versions of the disease, scientists found that a certain regimen of chemotherapy is more effective on one tumor type, while another drug works best on the other. The study authors said their findings would help doctors more effectively treat gastric cancer patients.

"Our study is the first to show that a proposed molecular classification of gastric cancer can identify genomic subtypes that respond differently to therapies, which is crucial in efforts to customize treatments for patients," study senior author Dr. Patrick Tan, associate professor in the Cancer and Stem Cell Biology Program at the Duke-National University of Singapore (NUS) Graduate Medical School, said in a university news release.

A microscopic pathology test developed in the 1960s, known as the Lauren classification, is a general description (either intestinal or diffuse) of how well the tumor cells clump together. The Singapore-based team at the Duke-NUS Graduate Medical School, however, was able to distinguish gastric cancer tumors where the Lauren test could not.

"There is a general assumption in the field that intestinal and diffuse gastric cancers [as classified by Lauren] represent two very different versions of gastric cancer, and now genomic data confirms this by demonstrating that the two genomic subtypes have very different molecular patterns," said Tan.

In profiling 37 stomach cancer cell lines, the researchers found two distinct patterns. Moreover, in accurately defining these tumor subtypes, they were also able to observe differences in how well each responded to chemotherapy.

"The exact mechanistic reasons for this difference are currently unclear, and this is an area that we are actively working on," noted Tan, adding that the researchers are working to find more specific vulnerabilities to drugs.

The researchers said they plan further research in which gastric cancer tumors will be genetically profiled to determine the most effective treatment.

The study findings were published in the Aug. 1 edition of Gastroenterology.

More information

The American Cancer Society has more about stomach cancer.

-- Mary Elizabeth Dallas

SOURCE: Duke-National University of Singapore Graduate Medical School, news release, Aug. 1, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Surgically shrinking the stomach when conservative weight-loss treatments fail
2. DNA from common stomach bacteria minimizes effects of colitis, U-M study says
3. Could Stomach Pacemaker Be New Weight-Loss Tool?
4. New fusion gene plays role in some stomach cancers
5. Heavy Beer Drinking, Genetics May Raise Risk of Stomach Cancer
6. Detection of early gastric cancer using hydro-stomach CT
7. How to Cope With Stomach Flu Symptoms
8. Common stomach bacteria may fight off inflammatory bowel disease caused by Salmonella
9. Stomach Ulcers Sending Fewer Americans to the Hospital
10. Western Diet Populates Kids Stomachs With Bad Bacteria
11. Simpler and cheaper antibiotic prophylaxis with insertion of nutrition catheter in the stomach
Post Your Comments:
Related Image:
Stomach Cancer Tumors Have Genetic Differences: Researchers
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... property taxes a year. In some states—like New York, New Jersey, Massachusetts, Texas, ... many overseas retirement havens have extremely low property-tax rates, which contributes to the ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
Breaking Medicine Technology: